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FAKTOR-FAKTOR RISIKO BAGI KEKURANGAN VITAMIN D DAN 
KESAN PENDEDAHAN CAHAYA MATAHARI SERTA SUPLIMENTASI 
VITAMIN D TERHADAP ARAS VITAMIN D SERUM, ADIPONEKTIN, 
FAKTOR RISIKO KARDIOMETABOLIK DAN METABOLIK SINDROM 




Walaupun dilimpahi dengan cahaya matahari yang banyak untuk penghasilan 
vitamin_D (VD) melalui kulit, aras VD yang rendah telah dilaporkan dalam kalangan 
rakyat Malaysia. Walau bagaimanapun, kesan pendedahan matahari berkaitan 
pekerjaan dan musim monsun ke atas VD masih belum cukup dikaji. Selain itu, aras 
VD yang rendah turut dikaitkan dengan beberapa penemuan yang tidak berkait dengan 
tulang atau kalsium termasuklah sindrom metabolik (MetS), yang mana mungkin 
diperantara oleh adiponektin. Kajian ini terbahagi kepada dua fasa. Fasa 1, kajian 
keratan rentas perbandingan telah dilaksanakan untuk mencirikan kesan pendedahan 
cahaya matahari berkaitan pekerjaan dan musim monsun ke atas 25-hydroxyvitamin 
D (25(OH)D) serum serta mengenalpasti faktor yang mempengaruhi aras 25(OH)D. 
Selain itu, hubungan di antara aras 25(OH)D dengan adiponektin berat molekul tinggi 
(adiponektin BMT) dan faktor risiko kardiometabolik turut dikaji. Fasa 2, kajian 
eksperimental berbentuk kuasi telah dijalankan untuk tempoh 12 minggu bagi menilai 
kesan pendedahan cahaya matahari secara sederhana [kumpulan pendedahan cahaya 
matahari; pendedahan cahaya matahari untuk 15 minit, 2 kali seminggu pada bahagian 
muka, tangan dan lengan serta kaki; n=19), pengambilan suplemen VD [kumpulan 
suplementasi VD, 50,000 IU cholecalciferol satu kali seminggu, n=15] dan placebo 
(kumpulan placebo, n=15) ke atas 25(OH)D serum, adiponektin BMT dan faktor risiko 




< 50 nmol/l). Kedua-dua fasa dilaksanakan dalam kalangan Melayu dewasa yang 
bekerja di Kelantan pada 2012 sehingga 2015. Pengukuran hasil kajian merangkumi 
pengukuran antropometri (tinggi, berat dan ukurlilit pinggang), penilaian peratus 
lemak tubuh dan tekanan darah, ujian darah berpuasa (25(OH)D, adiponektin BMT, 
profil lipid, glukosa, insulin dan hs-CRP) serta borang soal selidik (sosio-demografi, 
sejarah perubatan, pendedahan dan perlindungan cahaya matahari, penilaian aktiviti 
fizikal serta pengambilan VD). Dalam fasa 1, sebanyak dua kali pengumpulan data 
dilakukan ke atas 138 pekerja luar (outdoor workers) dan 143 pekerja dalam (indoor 
workers), pertama ketika musim bukan-monsun (Mei-Jun 2012) dan kedua ketika 
musim monsun (Jan-Feb 2013). Hasil kajian fasa 1 mendedahkan bahawa aras 
25(OH)D serum adalah lebih tinggi secara signifikan dalam kalangan pekerja luar 
berbanding pekerja dalam tanpa mengira musim dan jantina (p<0.001). Malah 
hubungan yang signifikan antara status VD dan jenis pekerjaan turut dilihat (p<0.001). 
Perbezaan musim monsun ke atas 25(OH)D hanya dilihat dalam kalangan pekerja luar 
lelaki (perbezaan min (MD) = 10.39 nmol/l, p<0.001). Walau bagaimanapun, secara 
keseluruhan, tiada hubungan yang signifikan ditemui antara status VD dan musim 
monsun (χ2(1)=0.076, p=0.783). Aras 25(OH)D serum adalah diramal secara langsung 
dengan jumlah jam pendedahan cahaya matahari (β=0.38, p=0.010) dan secara 
berlawanan arah oleh skor perlindungan cahaya matahari (β=-4.64, p=0.001), indeks 
jisim tubuh (β=-1.02, p=0.002), pekerja dalam (β=-42.72, p<0.001) dan jantina wanita 
(β=-19.46, p<0.001). Tiada hubungan yang signifikan di antara VD dengan 
adiponectin BMT dan faktor risiko kardiometabolik ditemui dalam kajian ini (p>0.05). 
Dengan mengambil kira keputusan faktor penentu VD dari fasa 1, pekerja dalam 
wanita dengan ketidakcukupan VD pada musim monsun dan bukan monsun telah 
direkrut untuk kajian fasa 2. Dalam fasa 2, selepas 12 minggu intervensi, aras 




(perbezaan min, MD=14.27 nmol/l, p<0.001) dan suplimen VD (MD=14.30 nmol/l, 
p<0.001) tetapi tidak dalam kumpulan placebo (MD=1.63 nmol/l, p=0.067). 
Peningkatan adiponektin BMT hanya diilihat dalam kumpulan suplementasi VD 
(MD=0.43 ng/ml, p=0.024). Dalam kalangan faktor risiko kardiometabolik, hanya aras 
glukosa menurun secara signifikan selepas 12 minggu terdedah kepada cahaya 
matahari (MD=-0.27 mmol/l, p<0.001) namun tiada perubahan ditemui dalam 
kumpulan lain. Tiada perubahan yang signifikan  bagi ukurlilit pinggang, tekanan 
darah, trigliserida dan faktor risiko kardiometabolik yang lain dalam semua kumpulan 
selepas 12 minggu. Walau bagaimanapun, HDL-C didapati meningkat secara 
signifikan dalam semua kumpulan selepas intervensi (p<0.05). Sebagai kesimpulan, 
kedua-dua intervensi pendedahan cahaya matahari secara sederhana dan suplimentasi 
VD meningkatkan aras VD, tetapi keberkesanan VD ke atas adiponektin BMT dan 










RISK FACTORS OF VITAMIN D DEFICIENCY AND THE EFFECTS OF 
SUNLIGHT EXPOSURE AND VITAMIN D SUPPLEMENTATION ON 
SERUM VITAMIN D LEVEL, ADIPONECTIN, CARDIOMETABOLIC RISK 





In spite of abundant sunshine for cutaneous vitamin D (VD) synthesis, low 
levels of VD have been documented among Malaysian population. However, the 
effects of occupational sunlight exposure and monsoon seasons on VD are not well 
established. Besides, low VD levels has been associated with several non-bone or 
calcium-related outcomes including metabolic syndrome (MetS), which may mediated 
by adiponectin. This study was divided into two phases. Phase 1, a comparative cross-
sectional study was conducted to characterize the effect of occupational sunlight 
exposure and monsoon season on serum 25-hydroxyvitamin D (25(OH)D) and identify 
factors modifying the serum 25(OH)D levels. Besides, the relationship between 
25(OH)D levels with high molecular weight (HMW) adiponectin and cardiometabolic 
risk factors were also observed. Phase 2, a quasi-experimental study was carried out 
for 12 weeks to evaluate the effects of moderate sunlight exposure (sunlight exposure 
group; 15 minutes sunlight exposure biweekly on face, arms, hands and feet; n=19), 
VD supplementation (VD supplement group, 50 000 IU cholecalciferol weekly, n=15] 
and placebo (placebo group, n=15) on serum 25(OH)D, HMW adiponectin and 
cardiometabolic risk factors in women with VD deficiency (serum 25(OH)D < 50 
nmol/l). Both phases were carried out among Malay working adults in Kelantan from 
2012 to 2015. Outcome measures comprises of anthropometric measurements (height, 




fasting blood test (25(OH)D, HMW adiponectin, lipid profile, glucose, insulin and hs-
CRP) and questionnaire (socio-demographic, medical history, sunlight exposure and 
sun protection use, physical activity assessment and VD intake). In phase 1, two-point 
data were collected in 138 outdoor and 143 indoor workers, first in non-monsoon 
(May-June 2012) and second in monsoon season (Jan-Feb 2013). Results of phase 1 
study revealed that serum 25(OH)D levels were significantly higher in outdoor 
workers compared to indoor workers irrespective of season and sex (p<0.001). 
Furthermore, significant association between VD status and occupation was observed 
(p<0.001). Monsoonal differences of 25(OH)D was observed only in male outdoor 
workers (mean difference, MD = 10.39 nmol/l, p<0.001). However, in overall, no 
significant association was found between VD status and monsoon season 
(χ2(1)=0.076, p=0.783). Serum 25(OH)D level was directly predicted by hours of 
sunlight exposure (β=0.38, p=0.010) and inversely by sun protection score (β=-4.64, 
p=0.001), body mass index (β=-1.02, p=0.002), indoor occupation (β=-42.72, 
p<0.001) and female sex (β=-19.46, p<0.001). No significant relationship between VD 
with HMW adiponectin and cardiometabolic risk factors were found in this study 
(p>0.05). Considering the results of determinants of VD in Phase 1, female indoor 
workers with VD deficiency in both monsoon and non-monsoon seasons were 
recruited for phase 2 study. In phase 2, after 12 week of intervention, serum 25(OH)D 
increased significantly in sunlight exposure (MD = 14.27 nmol/l, p<0.001) and VD 
supplement group (MD = 14.30 nmol/l, p<0.001) but not in placebo group (MD = 1.63 
nmol/l, p=0.067). Significant increase in HMW adiponectin was observed only in VD 
supplement group (MD=0.43 ng/ml, p=0.024). Among the MetS components, only 
glucose decreased significantly after 12 weeks of sunlight exposure (MD=-0.27 
mmol/l, p<0.001) but no changes seen in the other groups. No significant changes were 




risk factors in all groups after 12 weeks. However, HDL-C was found increased 
significantly in all groups after the intervention (p<0.05). In conclusion, both moderate 
sunlight exposure and VD supplement interventions improved the VD levels, but the 









Vitamin D, the sunshine vitamin is a fat soluble secosteroids (Cesari et al., 
2011) occurring naturally in five forms (D1 – D5). The predominant forms of  
vitamin D are vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Both 
vitamin D2 and vitamin D3 can be obtained from the diet (foods or supplements) but 
only vitamin D3 can be produced naturally by endogenous photosynthesis in the skin 
after solar ultraviolet B (UVB) radiation (wave length 280-315 nm) (Lehmann and 
Meurer, 2010). Sunlight exposure is the major source of vitamin D and its covers 90% 
of vitamin D production in human (Holick, 2003; Stroud et al., 2008). Endogenous 
(skin pigmentation and thickness) and exogenous factors (weather, time of day and 
lifestyle) influence the cutaneous (skin) production of vitamin D (Azizi et al., 2009; 
Holick, 2004).  
Vitamin D deficiency (VDD), reflected by circulating 25-hydroxyvitamin D 
(25(OH)D) levels  < 50 nmol/l or 20ng/ml is a global health problem affecting all age 
groups (Holick and Chen, 2008; Lhamo et al., 2017) even in low latitude countries 
where abundant UVB rays for cutaneous vitamin D synthesis. Besides, poor 
vitamin_D status were also reported in industrialized countries where fortification of 
food with vitamin D has been implemented (Palacios and Gonzalez, 2014). In 
Malaysia, despite close proximity to the equator and plentiful sunlight, high prevalence 
of  VDD (more than 70%) has been reported in Malaysian adults (Chin et al., 2014; 




The classic role of vitamin D for normal skeletal development and maintenance 
in preventing bone diseases is well established (Christodoulou et al., 2013; Holick, 
2006). In the recent decades, increasing evidence suggests that vitamin D plays an 
important role of various non-classical actions that may be important in the 
pathogenesis of many chronic diseases (Holick 2007; Muscogiuri et al., 2014; Wang 
et al., 2017). The non-classical effect of low vitamin D levels has been associated with 
muscle weakness, cancer, multiple sclerosis, cardiovascular disease (CVD), diabetes 
mellitus (DM) and all-cause mortality (Muszkat et al., 2010; Zittermann and Gummert, 
2010a). This is due in part to widespread expression of vitamin D receptor (VDR) in 
most tissues and cells (Bikle, 2014) such as heart, kidney, immune cells, brain and 
muscle (Gonzalez-Parra et al., 2012).  
Metabolic syndrome (MetS) is comprised of several abnormalities that occur 
together in which represents a clustering of risk factors for CVD and type 2 diabetes. 
Based on the harmonized definition of MetS by International Diabetes Federation 
(IDF) 2009, five risk factors were identified. These risk factors include raised blood 
pressure, raised triglycerides (TG), lowered high-density lipoprotein cholesterol 
(HDL-C), raised fasting glucose, and elevated waist circumference. Existence of any 
three of these risk factors would qualify a person for the MetS (Alberti et al., 2009).  
In Malaysia, 25 to 40% adults were affected by MetS (Lim and Cheah, 2016) and the 
risk increases with age, sex (female), ethnicity (Indian) and abdominal obesity (Ashari 
et al., 2016; Mohamud et al., 2011).  
Altered function of adipose tissues impact significantly on whole-body 
metabolism and represent a key driver of MetS development (Armani et al., 2017). 
Adipokines (biologically active substances secreted by adipose tissue) were recently 




Among the different adipokines, adiponectin is seen to be “protective” adipokine and 
highly significant in the development of MetS (Esfahani et al., 2015; Fisman and 
Tenenbaum, 2014).   
Adiponectin is the most abundant circulating adipokine and is recognized as a 
key component in regulating insulin sensitivity, glucose and lipid metabolism besides 
anti-inflammatory and anti-atherogenic properties (Ahima, 2006; Esfahani et al., 
2015). Adiponectin exists in three forms: a low molecular weight trimer (LMW), a 
medium molecular weight hexamer (MMW) and a larger multimeric high molecular 
weight (HMW) form (Aso et al., 2006). Consistent findings showed that low level of 
adiponectin is associated with most of the cardiometabolic risk factors (Calton et al., 
2013; Ding et al., 2015) and, furthermore decreased HMW Adiponectin is suggested 
as predictor of the progression to MetS (Seino et al., 2009).  
Emerging data suggest that vitamin D is the novel risk markers for MetS. It has 
been hypothesized that vitamin D may act through adiponectin to modulate MetS 
(Calton et al., 2013; Nimitphong et al., 2009). Recent evidence showed that  
vitamin D concentration are positively associated with circulating adiponectin level, 
and this association varies across body mass index (BMI) classification among adults 
(Bidulescu et al., 2014; Nimitphong et al., 2009; Vaidya et al., 2012). Since both 
vitamin D and adiponectin have a favorable effects on cardiometabolic risk factors 
(Bidulescu et al., 2014; Calton et al., 2013; Kardas et al., 2013), the interaction 
between vitamin D–adiponectin may be an indicator of MetS.  
In view of that, this study was embarked to understand the associated factors 
of vitamin D and to investigate the association between vitamin D with HMW 
adiponectin and cardiometabolic risk factors. The research work of this study 




study. Both studies were carried out among Malay outdoor and indoor workers in 
Kelantan state, Malaysia from 2012 to 2015. 
 
 Problem statement 
Known as ‘sunshine vitamin’, sunlight exposure is a major and natural source 
of vitamin D. Cutaneous synthesis of vitamin D provide 90% of vitamin D production 
in human. Vitamin D level significantly associated by occupational sunlight exposure 
and seasonal variations (Azizi et al., 2009; Devgun et al., 1981). It has been 
demonstrated that indoor workers, shiftworkers and healthcare workers were at high 
risk of VDD (Sowah et al., 2017). Besides, the influence of seasonal variation in 
vitamin D status has been acknowledged and high prevalence of VDD during winter 
months was recognized (Bolland et al., 2007; Mithal et al., 2009).  
Although some research has been carried out on the relationship between 
vitamin D with occupations and seasonal variations, the effects of prolonged periods 
of rain during monsoon season on vitamin D levels is not well documented. 
To the best of researchers' knowledge, there is no previous study that has investigated 
simultaneously the effects of occupation and dry/rainy season on vitamin D in 
Malaysia and other countries. In Malaysia particularly, the knowledge on the effects 
of different occupational groups on vitamin D level are still scarce. Earlier studies of 
vitamin D among Malaysian focused on ethnic comparison (Chin et al., 2014; Green 
et al., 2008; Rahman et al., 2004), Malay employee (Moy, 2011), pregnant women 
(Jan Mohamed et al., 2014) and urban-rural differences (Nurbazlin et al., 2013). 
Therefore, this study aims to contribute to research on vitamin D in Malaysia by 




A number of researchers have examined the effects of high dose vitamin D 
supplementation either globally (De Niet et al., 2018; Mozaffari-Khosravi et al., 2015; 
Sollid et al., 2014; Vieth et al., 2004) or locally (Ramly et al., 2014). However, little 
is known about the efficacy of modest direct sunlight exposure in increasing 
vitamin_D level particularly among Malay adults. Experimental studies on the effects 
of UV exposure on vitamin D were mostly conducted by using artificial sunlight such 
as sunbed or UV light cabin (Bogh et al., 2012; Lagunova et al., 2013). Studies in 
Thailand (Watcharanon et al., 2018), UAE (Dawodu et al., 2011) and Finland 
(Karppinen et al., 2017) have investigated the effects of natural sunlight exposure on 
vitamin D level, but the finding of these studies are inconclusive. Therefore, this study 
aims to contribute to this growing area of research by exploring simultaneously the 
effects of two vitamin D sources (modest direct sunlight exposure and vitamin D 
supplement) on vitamin D levels among Malay female indoor workers. 
In recent decades, there has been an increasing interest in non-skeletal role of 
vitamin D in protecting other systems and preventing chronic diseases including MetS. 
The mechanisms in which vitamin D may protect against cardiometabolic risk factors 
include activation of the renin-angiotensin-aldosterone systems, increase arterial 
intimae thickness and enhancement in insulin secretion and insulin sensitivity (Holick, 
2011). The role of vitamin D in regulating MetS may partly mediated by adiponectin. 
However, the evidence from available research is insufficient and inconsistent in 
findings (Baziar et al., 2014; Nimitphong et al., 2009; Vaidya et al., 2012). Thus, it is 
hoped that this study can provide a better understanding of the relationship between 
these variables (vitamin D, adiponectin, cardiometabolic risk factors and MetS) 





 Significance of study 
This study addressed the role of occupation, sunlight exposure and monsoon 
season on vitamin D level. Moreover, the effects of sensible, moderate sunlight 
exposure and vitamin D supplement on serum 25(OH)D were investigated. The results 
of this finding would be very useful to society and policy makers in terms of improving 
systemic vitamin D level. It could be applied in practice as an alternative approach to 
improve vitamin D status, in which to reduce VDD and ensure improved population 
health outcomes. 
This study too investigates the relationship between vitamin D with 
adiponectin and cardiometabolic risk factors. For researcher, this finding will 
contribute to knowledge and understanding of the causal relationship between vitamin 
D with adiponectin in relation to cardiometabolic risk factors which could help to set 
new strategies for the improvement of the condition in the future. Thus, the findings 
will redound to the benefit of society considering that MetS is a major public health 
problem, which has close association with adiposity, diabetes and CVD. With 
vitamin_D and adiponectin are emerging as potential biomarkers for MetS, both could 
be a promising target for prevention and treatment of MetS and related diseases.  
 
 Research question 
a. Phase 1 
i. Is there any difference in serum level of 25(OH)D between outdoor and indoor 
workers during non-monsoon and monsoon season?  
ii. What are the potential determinants of serum 25(OH)D level during non-




iii. Does the serum 25(OH)D level have an influence on HMW Adiponectin and 
the cardiometabolic risk factors? 
 
b. Phase 2  
i. Is there mean 25(OH)D difference between or within treatment groups 
(sunlight exposure, vitamin D supplementation and placebo) based on time? 
ii. Are there any changes in mean HMW adiponectin and cardiometabolic risk 
factors within treatment groups (sunlight exposure, vitamin D supplementation 
and placebo) based on time? 
 
 Study Objectives 
1.5.1 General objective 
This study aimed to identify the risk factors of vitamin D deficiency and to investigate 
the effects of sunlight exposure and vitamin D supplementation on serum vitamin D 
concentration, adiponectin and cardiometabolic risk factors among Malay adults in 
Kelantan. 
 
1.5.2 Specific objective 
a. Phase 1 
i. To compare serum 25(OH)D between outdoor and indoor workers during 
monsoon and non-monsoon season among Malay adults in Kelantan. 
ii. To examine the determinants of serum 25(OH)D level during non-monsoon 
and monsoon season among Malay adults in Kelantan. 
iii. To determine the relationship between serum 25(OH)D with HMW 






b. Phase 2 
i. To determine and compare the changes in serum 25(OH)D level following 12 
weeks intervention by different interventions (sunlight exposure, vitamin D 
supplementation or placebo) among Malay female indoor workers in Kelantan. 
ii. To determine and compare the changes in HMW adiponectin and 
cardiometabolic risk factors following 12 weeks intervention by different 
treatments (sunlight exposure, vitamin D supplementation or placebo) among 
Malay female indoor workers in Kelantan. 
 
 Alternative hypothesis 
a. Phase 1 
i. The mean serum 25(OH)D are significantly difference between outdoor indoor 
workers during non-monsoon and monsoon season. 
ii. There will be a significant prediction of serum vitamin D by occupation, sex, 
sun exposure, sun protection, physical activity, dietary vitamin D intake & BMI 
(at least 1 independent variable).  
iii. Serum 25(OH)D significantly related with HMW Adiponectin and 
cardiometabolic risk factors. 
 
b. Phase 2 
i. At least one of the mean serums 25(OH)D are significantly difference between 
or among treatment groups. 
ii. Vitamin D supplementation or sunlight exposure significantly improve the 





 Conceptual framework 
The primary outcome measure for this study is vitamin D. In the first phase, 
the study was focused on the determinants of vitamin D levels. The significant 
predictors from the outcome of phase 1 were used as the foundation for the study 
design in phase 2. Meanwhile, adiponectin, cardiometabolic risk factors and MetS 
were the secondary outcome measures of this study. 
Figure 1.1 shows the overall concept of the study. Vitamin D can be obtained 
from two sources. First, from direct sunlight exposure of which covers 90% of 
vitamin_D production in human through cutaneous synthesis after solar UVB 
radiation. Second, from dietary sources either from natural foods, vitamin D fortified 
foods or vitamin D supplements. Low sunlight exposure usually observed among 
women, those who use sun protection, people with indoor occupation, older 
individuals and during season where there is very little daylight and sunlight available 
such as winter or rainy season. Low serum vitamin D levels reflect decrease in 
cutaneous synthesis, poor dietary intake of vitamin D and low physical activity. Lack 
of physical activity result in poor anthropometric status in which leads to adiposity 
and, therefore, decrease the serum vitamin D levels.  
Greater adipose tissue leads to greater circulating fatty acids, hypo-secretion of 
adiponectin and decrease the bioavailability of vitamin D. This condition may trigger 
chronic low-grade inflammation of metabolic tissues, including skeletal muscle and 
liver, which results in insulin resistance. Insulin resistance plays a key role in the 
pathophysiology of MetS, in which leads to increased blood glucose, blood pressure 
and triglyceride as well as reduced circulatory HDL-C. Additionally, the roles of 
vitamin D may mediated by adiponectin to modulate MetS through renin-angiotensin 









 Operational terms definition 
 
Adiponectin – a protein hormone produced and secreted by adipose tissues (fat cells). 
In this study the adiponectin was determine by measuring the high molecular weight 
isoform which is known as HMW adiponectin. 
 
Cardiometabolic risk factors – risk factors that increase the likelihood of 
experiencing vascular events or developing diabetes (Chatterjee et al., 2012). In this 
study the cardiometabolic risk factors consist of metabolic syndrome related 
biomarkers such as glucose, insulin, lipid profile, hs-CRP, blood pressure and waist 
circumference. 
 
HMW Adiponectin – an active form of Adiponectin protein and a good predictor of 
metabolic abnormalities. 
 
Indoor workers – indoor workers in this study were defined as those who stayed 
indoors more than half of their working hours (office staff) for phase 1, and at least ¾ 
of working hours in phase 2.  
 
Metabolic syndrome (MetS) – is a group of conditions that often occurs together and 
can increase the risk of having diabetes or CVD. The definition of MetS in this study 
was in accordance with the Harmonized International Diabetes Federation (IDF) for 
MetS 2019 (Alberti et al., 2009). 
 
Monsoon season - the periods when northeast monsoon (NEM) occurred at the study 
area (November 2012 to February 2013). 
 
Non-monsoon season - the periods when the study area was not affected by northeast 





Occupational sunlight exposure – exposure to ultraviolet radiation (UVR) from the 
sunlight through skin or eyes that may result from the performance of an employee's 
duties. 
 
Outdoor workers – in this study outdoor workers were defined as those who 
experienced occupational sunlight exposure for more than 2 hours/day between 8.00 
am to 2.00 pm (fishermen). 
 
Seasons – season in this study refer to the period of non-monsoon and monsoon takes 
place. 
 
Serum 25(OH)D – serum level/concentration of vitamin D. 
 
Ultraviolet (UV) radiation – specific portion of the sun’s energy reaching the earth’s 
surface (the electromagnetic spectrum between 100–400 nm). 
 
Vitamin D status – for this thesis, vitamin D status refer to the classification of 
vitamin D level [25(OH)D], which based on the Endocrine Society Clinical Practice 
Guideline (Holick et al., 2011), as follows: sufficient (≥75 nmol/l), insufficient  








 LITERATURE REVIEW 
 
 The climate of Malaysia 
 
2.1.1 Monsoon seasons 
Malaysia including others Southeast Asian countries are influenced by a 
monsoon (Loo et al., 2015). The word “monsoon” comes from the Arabic word 
“mausim”, which means season. Monsoon is defines as the large-scale seasonal 
reversal of the wind direction (prevailing wind) over a region. It is caused by a 
difference in thermal circulations between a landmass and the adjacent ocean (Ahrens 
and Henson, 2016). 
Monsoon always blows from cold to warm region. The Asian monsoon results 
from a reversal of the winds between the winter and summer. During winter, the air 
over landmass colder than the air over the adjacent ocean. The surface winds blow 
from land to ocean leading to clear skies and generally dry weather. When summer 
arrives, the wind direction shift itself as air over landmass becomes much warmer than 
air above the ocean. The surface winds blowing from ocean to land and bring large 
amounts of water vapor to produce heavy rainfall over land. Monsoon cause wet and 
dry seasons over tropical and near-tropical regions and greatly affect these region’s 
climate (Aguado and Burt, 2015b; Ahrens and Henson, 2016). 
Malaysia’s climate and weather are governed by the regime of two monsoon 
seasons, namely, the Northeast Monsoon (NEM) from November to March (winter 
monsoon), and the Southwest Monsoon (SWM) from late May to September (summer 





The NEM is characterized as a wet season and associated with cloudy 
conditions and frequent afternoon shower. It is caused by the steady strengthening of 
easterly or northeasterly winds (10 to 20 knots) blowing from the South China Sea 
which originate from cold air of Siberia.  During this season, four to five episodes of 
monsoon surges are normally expected (MMD, 2017b). Monsoon surges refer to 
strong outbursts of cold air due to sudden increase in wind speed (may reach 30 knots 
or more) into the South China Sea. It could bring a continuous, moderate to heavy 
rainfall lasting two to five days, occasionally windy conditions and a few days of 
cooler temperatures (NEA,(2015b). Lack of sunlight and less solar radiation are 
expected during this period due to overcast and cloudy conditions with extensive cloud 
cover (MMD, 2017b). 
Areas affected by the NEM includes east coast of Peninsular Malaysia, 
Western Sarawak and the northeast coast of Sabah (MMD, 2017b). The west coast 
region of Peninsular Malaysia is less influenced by this monsoon due to the existence 
of the Titiwangsa Range which blocks the region from receiving heavy rainfall. This 
region denoted as the driest area but still receive 41% of total rainfall from the 
northeast monsoonal flow. The NEM contribute 55% of the total annual rainfall of the 
east coast region of Peninsular Malaysia and strongly influenced the rainfall 
characteristics (e.g. total amount of rainfall, rainfall intensity and frequency of wet 
days) of this region (Suhaila et al., 2010; Wong et al., 2009). Besides, this region 
considered as the wettest area during the NEM season (Deni et al., 2009).  
The SWM caused by light southwesterly winds (below 15 knots) blowing from 
Sumatra, originating from the Southern Indian Ocean. Except for Sabah, the period of 
this monsoon is relatively drier throughout the country, especially Peninsular Malaysia 




37% and 31% of the total annual rainfall of the west coast and east coast region of 
Peninsular Malaysia, respectively (Wong et al., 2009). In term of rainfall 
characteristics, the west coast region of Peninsular Malaysia is greatly affected by the 
SWM where the northwest region considered as the wettest area during this season 
(Suhaila et al., 2010). 
 
2.1.2 Malaysia weather and climate 
Malaysia’s climate is described by uniform temperature (max. 33ºC, min. 
23ºC), high humidity (70 – 90%), copious rainfall and usually light wind.  Located in 
equatorial region, Malaysia is granted with abundant of sunlight with an average of six 
hours per day. The amount of sunlight and solar UVR are influenced by cloud cover 
which consequently affects temperature (MMD, (2017a). The flux of solar UVR 
maximum in March and September. During clear days, the solar UV radiation is high 
or extreme for about 5 hour, starting at 10.30 a.m. throughout the year (Ilyas et al., 
1999). 
As maritime country, a full day with completely clear sky is extremely rare 
even during severe drought but during the days with clear skies, the effects of land and 
sea breeze on the general wind flow pattern is very marked (MMD, 2017a). The 
rainfall distribution of the country is determined by seasonal wind direction together 
with local topographic characters. The country experience more than 170 rainy days 
with rainfall commonly in the afternoon or early evening (Azhari et al., 2008). A total 
of 81% of the mean annual rainfall is originated from monsoon rainfall  (Wong et al., 




 Overview of vitamin D 
Vitamin D exists in nature in two major forms: vitamin D2 (ergocalciferol) and 
vitamin D3 (cholecalciferol). Vitamin D2 is made by invertebrates, some plants and 
fungi in response to UV radiation (Nair and Maseeh, 2012). It synthetically prepared 
from radiating a compound (ergosterol) from the mold ergot or from UV treated 
mushrooms (Moyad, 2009). According to Houghton and Vieth (2006), vitamin D2 was 
first produced and patented in the early 1920s by exposing foods to UV exposure and 
since then it has been licensed to pharmaceutical companies for use in prescription 
vitamins. Vitamin D3 is the most “natural” form of vitamin D. It is synthesized in the 
skin following exposure to ultraviolet B radiation (UVB, spectrum 280 to 315 nm) 
(Chen et al., 2007). Since it can be formed in the body by direct sunlight, Vitamin D 
is often referred to as the ‘sunshine vitamin’. 
 
2.2.1 Sources of vitamin D 
Vitamin D may be obtained from two sources: sunlight and dietary intake. 
Sunlight is the best and major source of vitamin D. Cutaneous synthesis of vitamin D 
involving UVB radiation which naturally initiates the conversion of 7-
dehydrocholesterol (7-DHC) in the skin to vitamin D3 (Chen et al., 2007). Sunlight 
induced vitamin D synthesis largely influenced by season, time of day, duration of 
exposure,  latitude, air pollution, skin pigmentation, sunscreen use, aging (Babaria and 
Watson, 2013; Nair and Maseeh, 2012) and passing through glass and plastic (Wacker 
and Holick, 2013). According to Holick (2001), exposure of hands, arms, and face to 
a half of a minimal erythema dose (1MED, time for skin to get a light pinkness or 




for two to three times a week is more than adequate to satisfy the body’s requirement 
of vitamin D.  
The dietary source of vitamin D include natural food, vitamin D fortified food 
and supplements. The combination of these dietary source of vitamin D reflects the 
‘total vitamin D intake’ of individuals (IOM, 2011). The natural food sources of 
vitamin D are limited. Vitamin D2 is found only in yeast and mushroom. Vitamin D3 
is primarily found in fish liver oils and fatty fish such as herring, tuna, salmon and 
mackerel. Small amounts of vitamin D are found in meat, offal, and egg yolks. Human 
milk and unfortified cow’s milk are poor sources of vitamin D (Ovesen et al., 2003; 
Schlenker, 2015). Vitamin D content of foods is given in Table 2.1. 
 
Table 2.1 Vitamin D content of foods 
Food Vitamin D ug/100 g 
(1ug = 40 IU) 
Poultry, Meat, Fish  
Fish, salmon, pink 10.9 
Fish, mackerel, cooked 7.3 
Fish, sardines, cooked 4.8 
Egg, whole 2.0 
Beef, liver 1.2 
Fish, catfish, farmed 0.2 
Beef, Meat 0.1 
Chicken, Meat 0.1 
Lamb, meat 0.1 
  
Dairy  
Milk, cow fortified, low fat 1.3 
Yogurt, fortified, low fat 1.2 
Cheese, cheddar 1.0 
  
Vegetables  
Mushroom, oyster 0.7 
Potatoes, mashed 0.3 
 
(Source: (NCCFN, 2017) 
 
It has become a practice in many countries to fortify certain frequently 




States (US) and Canada, vitamin D is routinely fortified in milk, baked goods, orange 
juices, cereals, yogurts and cheeses while in European countries, fortified margarine 
is the major dietary source of vitamin D (Holick, 2010a). In Malaysia, milk powder 
for children and adults are recently fortified with vitamin D on a voluntary basis by 
manufactures (Jan Mohamed, 2017). Vitamin D is also added in many formulated 
nutritional supplements as other possible source of Vitamin D. Both vitamin D2 and 
vitamin D3 are use in foods fortification and supplement products. Multivitamin 
supplements often contain 400 IU (10 mg) vitamin D, and pharmaceutical preparations 
of vitamin D contain as much as 50,000 IU (1250 mg) vitamin D2 per capsule or tablet 
(Combs Jr and McClung, 2016).  
 
2.2.2 Vitamin D metabolism 
Figure 2.1 illustrates a basic metabolism of vitamin D in human. Upon 
exposure to UVB radiation, previtamin D3 is synthesized by the photolytic cleavage of 
7-DHC in the skin, primarily in epidermal keratinocytes. Then through thermal 
isomerization reactions, previtamin D3 isomerizes to form vitamin D3 (Dusso et al., 
2005; Holick et al., 1980).  
Cutaneously synthesized vitamin D3 or vitamin D from the diet enters the 
systemic circulation bound to vitamin D-binding protein (DBP). Once in circulation, 
the inert vitamin D2 or vitamin D3 is converted to 25-hydroxyvitamin D (25(OH)D, 
calcidiol) by a hepatic 25-hydroxylase (CYP2R1, mitochondrial enzyme). The 
25(OH)D is the main circulatory vitamin D metabolites, with a serum half-life is 
approximately 15 days (Keane et al., 2017; Mostafa and Hegazy, 2015). The 25(OH)D 
is further hydroxylated by mitochondrial CYP27B1 (1α-hydroxylase) in the proximal 




active hormonal form of vitamin D (Nair and Maseeh, 2012). This active 1,25(OH)D 
has a short serum half-life of approximately 6 hours (Keane et al., 2017).  
 
 
Figure 2.1 Vitamin D metabolism 
(Source: (Keane et al., 2017) 
 
The biologic actions of 1,25(OH)D are mediated by a soluble receptor protein 
termed the vitamin D receptor (VDR) (Dowd and MacDonald, 2010). The VDR binds 
1,25(OH)D to form a hormone-receptor complex in target cells (Kreutz et al., 1993), 
which has its biological effect through gene transcriptions (Bikle, 2014; Dowd and 
MacDonald, 2010; Kreutz et al., 1993). To avoid toxicity, the 1,25(OH)D induces its 




expression (24-hydroxylase) that catalyzed the conversion of 25(OH)D and 
1,25(OH)D to calcitroic acid, an inactive water-soluble vitamin D metabolites (Jones 
et al., 2012; Keane et al., 2017).  
 
2.2.3 Assessing vitamin D status 
The status of vitamin D is evaluated by measuring the prohormone 25(OH) D, 
which is the most stable and abundant vitamin D metabolite (Thacher and Clarke, 
2011). It is recognized as the optimal indicator of vitamin D status (Jassil et al., 2017). 
The circulating concentration of 25(OH)D reflects both UV exposure and dietary 
intake of vitamin D (Mostafa and Hegazy, 2015). Assay methods to measured 
25(OH)D includes radioimmunoassay (RIA), electrochemiluminescence (ECL), 
ELISA, HPLC-UV, and HPLC-mass spectrometry (LC/MS). The non-HPLC methods 
typically detect both vitamin D2 and D3 and thus the results produce are referred to as 
‘total’ 25(OH)D (Heaney, 2011).  
 Defining vitamin D deficiency or insufficiency based on 25(OH)D values is 
still debated. Although different opinions exist on how to classify vitamin D status,  
the vast majority of vitamin D researchers agree that 25(OH)D levels below 50 nmol/l 
(20 ng/ml) are insufficient (Zittermann and Gummert, 2010b). The US Institute of 
Medicine (IOM) has stated that 25(OH)D levels below 30 nmol/l (12 ng/ml) and 
between 30 - 50 nmol/l as deficient and insufficient, respectively. Meanwhile, the 
25(OH)D levels at or above 50 nmol/l is defined as sufficient. This statement was set 
based on beneficial vitamin D effects with regard to prevention of rickets and/or 
symptomatic osteomalacia (IOM, 2011). In strong opposition to this classification, the 
US Endocrine Society Task Force has defined vitamin D deficiency as a serum 




ng/ml). The recommendation is set higher in order to maximize the effect of vitamin 
D on calcium, bone and muscle metabolism (Holick et al., 2011). Vitamin D toxicity 
occurs at 25(OH)D levels above 500 nmol/l (Kimball and Vieth, 2008). 
 
2.2.4 Recommended nutrient intake for vitamin D 
The recommended nutrient intake (RNI) for vitamin D is established to meet 
the body's needs when a person has inadequate exposure to sunlight, and the tolerable 
upper intake levels (UL) are set at those considered to pose no risk of adverse effects. 
The preferred units for quantification of vitamin D are micrograms (ug), in which 1 ug 
equals 40 IU of vitamin D (Gallagher, 2008).  
The RNI of vitamin D for Malaysian adults, age 19 to 65 years is 15 ug (600 
IU) per day with an assumption of minimal sunlight exposure (NCCFN, 2017). This 
recommendation for adults is considered based on the relationship between calcium 
absorption and vitamin D levels, in which serum vitamin D levels between 30 and 50 
nmol/l were consistent with maximal calcium absorption (IOM, 2011). Except for 
infants (0-11 months) and elderly (> 65 years), the RNI of vitamin D for others age 
groups are also recommended at 15 ug/day. The amount of 10 ug and 20 ug vitamin D 
per day are recommended for infant and elderly, respectively (NCCFN, 2017). The UL 
for vitamin D for children and adults are 100 ug/day (4000 IU/day) while for infants 
is below 37.5 ug/day (IOM, 2011).  
 
2.2.5 Recommended sunlight exposure for cutaneous vitamin D synthesis 
Solar UV exposure may provide an alternative to vitamin D supplement for 
prevention and treatment of VDD. Among UV spectrum, only UVB (280-315 nm) can 




sunbathing in swimsuit to 1MED (skin slightly pink) increased vitamin D equivalent 
to 10 000 to 20 000 IU vitamin D taken orally (Holick, 2001). It has been estimated 
that exposing arms and legs (about 25% of body surface area, BSA) to ¼ and ½ MED 
provides approximately 2000 to 4000 IU vitamin D.  
From these findings, the ‘Holick Formula’ was developed and have been widely 
used as a reference to get the sensible amount of sunlight exposure. The formula 
requires individuals to expose 25% of BSA to 25% of 1MED two to three times a week 
throughout a year whenever the sunlight is available. The 1MED time is based on the 
individuals skin type, and for adults with skin type II (white skin), about 5 minutes are 
required to get 25% of 1MED. The amount of vitamin D produced from this formula 
equivalent to 1000 IU oral vitamin D (Dowdy et al., 2010; Holick and Jenkins, 2009; 
Holick, 2010b).  
Another recommendation for sunlight exposure was based on the “shadow rule”. 
The body is able to make vitamin D when a person’s shadow is less than the person’s 
height (Holloway, 1992) which happen between 10 a.m. to 3.0 p.m. (Holick, 2010b). 
UV exposure is well known as a major risk factor for skin cancer. Thus, it is important 
to avoid excessive UV exposure, particularly getting sunburned (Mason and Reichrath, 
2013). Safety precaution includes wearing sunglasses and sunscreen if planning to be 
in direct sunlight for extended periods of time. 
 
 Determinants of vitamin D status 
 
2.3.1 Determinants of cutaneous vitamin D synthesis 
Any factors that absorbs and prevent UVB radiation will reduce the cutaneous 
synthesis of vitamin D3. The determinants of cutaneous synthesis of vitamin D3 are 




exogenous factors affecting sunlight exposure. The endogenous factors include 
melanin pigmentation and skin thickness. Meanwhile, the exogenous factors include 
latitude, season, time of day, pollution, weather conditions and lifestyle such as 
sunscreen use, clothing, and indoor living. (Chen et al., 2010; Combs Jr and McClung, 
2016; Holick, 1995; Lips et al., 2014).   
 
a) Melanin pigmentation and skin thickness 
Epidermal cells are mostly keratinocytes, with melanocytes in the basal layer 
producing melanin that determines pigmentation of the skin (Cichorek et al., 2013). 
Melanin is an efficient natural sunscreen that effectively absorbs solar UV radiation 
from 280 to 700 nm, including UV-B radiation (280-315 nm). Therefore, melanin 
pigmentation can reduce the efficiency of previtamin D3 synthesis in the skin by 
competing for UV-B photons with 7-DHC which is substrate for making vitamin D 
(Chen et al., 2010; Holick, 1995). Dark-skinned individuals have high amounts of 
melanin, thus require greater UV doses and longer UVR exposure to photosynthesize 
the equal amount of vitamin D3 than light-skinned individuals (Chen et al., 2010; 
Clemens et al., 1982).   
It has been known, that aging causes various dermatologic changes. According 
to Tan et al. (1982), skin thickness decline linearly with age after the age of 20 years. 
This is corresponded with decreased in 7-DHC content in the epidermis. A comparison 
of the amount of previtamin D3 produced in the skin of the young subjects (8- and 18-
year-old) with the amount produced in elderly (77- and 82-year-old) revealed that 
aging decreased the skin’s capacity by more than twofold of previtamin D3 production. 
Thus, advancing age decreases 7-DHC due to skin thinness and markedly diminish the 





b) Latitude, season and time of day. 
The solar zenith angle (SZA) is the angle between the vertical line at a place 
on earth (known as zenith) and the line joining the place to the sun (Figure 2.2). When 
the solar is directly overhead and on the horizon, the SZA is at 0º and 90º respectively. 
This angle is affected by change in latitude, season of the year and time of day (Chen 
et al., 2010; Webb et al., 1988).  
  
 
Figure 2.2 The solar zenith angle 
(Source:(Pal and Das, 2015) 
 
 
An alteration in the SZA have a significant impact on the amount of UVB 
radiation available for cutaneous vitamin D synthesis (Engelsen, 2010). As the SZA 
increases or at a more oblique angle, the amount of UVB radiation reaching the earth’s 
surface is decreased. This is because most of the UVB photons are absorbed by the 
stratospheric (10 to 50 km from earth) ozone layer (Holick, 2010b; Webb et al., 1988). 
Thus, UVB radiation is the highest at noon (60% occurs between 10 a.m. and 3 p.m.), 
reaching an annual peak during the summer months, and declining with the distance 
from the earth’s equator (Combs Jr and McClung, 2016; Holick, 2010b).  
